Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Randomized Double Blind Controlled Study to Evaluate the Safety and Immunogenicity of GPO Seasonal Trivalent Inactivated Split Virion Influenza Vaccine in Healthy Thai Adults Aged Between 18 Years to 49 Years

NCT02894840 is registered in ClinicalTrials.gov with Mahidol University as lead sponsor.

NCT NCT02894840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02894840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Randomized Double Blind Controlled Study to Evaluate the Safety and Immunogenicity of GPO Seasonal Trivalent Inactivated Split Virion Influenza Vaccine in Healthy Thai Adults Aged Between 18 Years to 49 Years
Lead sponsor
Mahidol University
Phase
Phase 1/2
Overall status
Completed
Start date
November 30, 2015
Completion date
November 30, 2016
Enrollment
340 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

influenza